about
Genome-wide association study identifies five loci associated with lung functionGenetic variants in novel pathways influence blood pressure and cardiovascular disease riskHundreds of variants clustered in genomic loci and biological pathways affect human heightNew genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskExcessive daytime sleepiness increases the risk of motor vehicle crash in obstructive sleep apneaA Comprehensive Evaluation of a Two-Channel Portable Monitor to "Rule in" Obstructive Sleep ApneaA genome-wide association search for type 2 diabetes genes in African AmericansApolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysmPsychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distributionAssociation of an allele on chromosome 9 and abdominal aortic aneurysm.Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.Statistical adjustment of genotyping error in a case-control study of childhood leukaemia.Defining the role of common variation in the genomic and biological architecture of adult human height.High prevalence of undiagnosed obstructive sleep apnoea in the general population and methods for screening for representative controls.A population-based study of polymorphisms in genes related to sex hormones and abdominal aortic aneurysmReducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009Childhood hospitalisation with infection and cardiovascular disease in early-mid adulthood: a longitudinal population-based studyPhysical Inactivity Is Associated with Moderate-Severe Obstructive Sleep ApneaA population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes.Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia.Inherited balanced translocation t(9;17)(q33.2;q25.3) concomitant with a 16p13.1 duplication in a patient with schizophrenia.Impact of Neuritin 1 (NRN1) polymorphisms on fluid intelligence in schizophrenia.Effect of Exercise Intensity on Glucose Requirements to Maintain Euglycemia During Exercise in Type 1 Diabetes.Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery.A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men.Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.School performance in children with type 1 diabetes: a contemporary population-based study.Impact of the Reelin signaling cascade (ligands-receptors-adaptor complex) on cognition in schizophrenia.Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents.Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm.Clinical and demographic risk factors associated with mortality during early adulthood in a population-based cohort of childhood-onset type 1 diabetes.Maternal smoking during pregnancy and the risk of childhood type 1 diabetes in Western Australia.Erratum: Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distributionErratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskSoluble Glycoprotein VI Is Raised in the Plasma of Patients With Acute Ischemic StrokeReal-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes
P50
Q24629653-F79A17EA-A8FB-48EF-8A1A-EDEFFFCCC902Q24630394-A88B9FF2-5B09-4734-A556-284A3B58AF06Q24630979-352FFD14-46A1-459F-A2F5-0E12F22077BCQ28270700-4748B751-05BB-4457-8B49-0B56401D0202Q28388880-196D3EB0-C3A4-46BE-86AE-C25A00C1C1B0Q28390121-890A6985-8FE4-4886-8C29-FFB1F7E7751DQ28740367-2E808C18-1474-4205-8E8D-985C710AD495Q33756098-FF655222-6B42-4FB7-9290-BD291711E904Q34124429-DDD8F515-FD08-4B39-8A00-595CD20B88F0Q34142739-F86DCD12-ACB7-4071-BF02-658E29B624C1Q34188620-E95DA5BB-AB20-415E-8389-A860A7F7D88BQ34221038-C5F38163-6F45-4D32-9CED-CEEAED332098Q34413077-35C99FEE-5399-4F9C-84CC-803CD70D82B8Q34441746-531A712D-7996-4079-8C11-004CACE4099BQ34645516-B46B5D60-BC4F-4552-B09E-AF4304A83FC2Q34705304-9945CEAD-A8DB-4136-B789-F2B804B02730Q35408129-F0A482A9-9BD3-4F06-885A-887C7071073EQ35566795-F47A874A-7C5E-4D3F-9D60-3C0B27F65AA7Q36090647-B8335D7F-A2A3-4C4D-980D-58AD937A1774Q38425571-7185CE3A-D761-4B98-B91D-E3A0EDCC5D2DQ39463718-21B00208-7D6F-4E17-857D-39E0E9FE575BQ39785277-51A7B347-19C5-47C8-A93E-FDAB18ABCD7BQ39966391-3F895791-E9F8-49FF-9072-A4EAF8323F96Q40109615-6A17B1F5-0BAB-4A28-B70B-CFDFBF154DFFQ43208434-ECAD3958-59EE-4185-9055-EB8FD6EAE33CQ43271696-98AE98A2-FDDB-4163-AA56-34E4532D49D4Q43289590-C6795931-7A4B-43F2-A6D3-BA0B644BEA6BQ44816602-9A4D6D91-E866-4599-B32C-8D586C444AD0Q45065209-38D1E145-BB89-46A1-9412-D50A6925437EQ45302237-9964181C-9E4B-4749-91C9-479D31045379Q46262150-FEEEDCA0-0981-43C7-AA08-31B9F60980EDQ47822384-FA7677E9-13D7-4765-BD55-D96FE3A2A8AAQ48274761-9A68BEE2-14E4-459E-8128-482AF0930E6FQ54501462-6DB84DEA-C485-475F-B8D9-14237AADCF4AQ56879641-94F09DD7-A676-4C97-8335-B670C1831970Q56879645-0368808B-1029-4413-8408-1603A4EB7916Q57306100-A696A95C-2332-4468-991E-335DC8CF7735Q91057622-94BDF636-70FE-45A6-9709-AFE62EC9D730
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Matthew N Cooper
@nl
Matthew N Cooper
@sl
Matthew N. Cooper
@en
Matthew N. Cooper
@es
type
label
Matthew N Cooper
@nl
Matthew N Cooper
@sl
Matthew N. Cooper
@en
Matthew N. Cooper
@es
altLabel
Matt
@en
Matthew Cooper
@en
prefLabel
Matthew N Cooper
@nl
Matthew N Cooper
@sl
Matthew N. Cooper
@en
Matthew N. Cooper
@es
P1053
J-4420-2014
P106
P1153
34970888100
P21
P31
P3829
P496
0000-0003-1139-3682